what would good news look like?, page-15

“What would good news look like?”

Some time ago, I posted the following:

“From what I’ve read, a good FDA result would not just be IND approval, but include as many of the following as possible:

- IIb/III trial protocols combined or dovetailed

-a low number of trial candidates, the rumoured approx. 60+ would be a great result. (Dendreon had to fund 500+)

-healthier trial candidates than in phase IIa (less degraded immune system, therefore potentially better response)

-the less trial sites (and countries involved) the better

- and most importantly a trial protocol with an end point dictating a ‘positive reaction’ to the treatment rather than a much (perhaps years) longer and therefore more expensive ‘survival rate’ criterion.”

On reflection, I now don’t see any reason to materially change any of that!

In my view, the content of this announcement will be pivotal in the future of PRR.

And I can't believe that a senior Pfizer exec would move fulltime to PRR if there was any doubt!

Good luck all.